Severe aortic stenosis (SAS), also known as heart valve failure, is a signal for danger—yet many patients may not realize it1,2
DELAYING REFERRAL MEANS PUTTING PATIENTS AT RISK
Patients who are referred for treatment often face a perilous race against the clock—1 in 10 symptomatic severe aortic stenosis patients can die within 5 weeks while awaiting treatment.3 Early referrals and intervention could prevent these deaths.
Don't let fixable become fatal. Refer your patients for an evaluation sooner
Why is a prompt referral so important for patients with symptomatic severe aortic stenosis?
“Undertreatment is really in large part determined by underreferral for the evaluation for an aortic valve replacement to specialized heart valve teams.”
-
Dr. Ankur Phatarpekar
Interventional Cardiologist
and Heart Valve Specialist
TAVI
There are various causes of mitral valve disease including structural deformity within the heart, congenital (by birth) defects, degenerative changes in the valve, or rheumatic fever.
There are various causes of mitral valve disease including structural deformity within the heart, congenital (by birth) defects, degenerative changes in the valve, or rheumatic fever.
There are various causes of mitral valve disease including structural deformity within the heart, congenital (by birth) defects, degenerative changes in the valve, or rheumatic fever.
There are various causes of mitral valve disease including structural deformity within the heart, congenital (by birth) defects, degenerative changes in the valve, or rheumatic fever.